Portfolio company
GenVec
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical-stage biotechnology company develops gene-based therapeutics and vaccines using a proprietary delivery platform for the biopharmaceutical industry.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
genemedicine
This company develops oncolytic adenovirus therapies for cancer patients and provides drug delivery systems and manufacturing services to the biotechnology sector.
Gene Therapy Delivery Methods
This company develops viral and non-viral vector platforms to provide genetic material delivery solutions for biotechnology firms and healthcare providers.
CEVEC
The company produces human cell-based expression systems and viral vector manufacturing technologies for biopharmaceutical firms and biotechnology organisations developing therapeutic proteins and gene therapies.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
BioVex
This biotechnology company develops oncolytic virus therapies and vaccines to treat solid tumours and prevent infectious diseases for healthcare providers and patients.
Aera Therapeutics
This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.
Salve Therapeutics
The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
